APA (7th ed.) Citation

Alroughani, R., Huppke, P., Mazurkiewicz-Beldzinska, M., Blaschek, A., Valis, M., Aaen, G., . . . Beynon, V. (2021). Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis. Frontiers in neurology, 11, 606418. https://doi.org/10.3389/fneur.2020.606418

Chicago Style (17th ed.) Citation

Alroughani, Raed, Peter Huppke, Maria Mazurkiewicz-Beldzinska, Astrid Blaschek, Martin Valis, Gregory Aaen, Joe Pultz, Xiaomei Peng, and Vanessa Beynon. "Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis." Frontiers in Neurology 11 (2021): 606418. https://doi.org/10.3389/fneur.2020.606418.

MLA (9th ed.) Citation

Alroughani, Raed, et al. "Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis." Frontiers in Neurology, vol. 11, 2021, p. 606418, https://doi.org/10.3389/fneur.2020.606418.